Response to: “Commentary on ‘Role of phototherapy in the era of biologics’” - 11/01/21
Doi : 10.1016/j.jaad.2020.09.040
Angeli Eloise Torres, MD, Alexis B. Lyons, MD, Iltefat H. Hamzavi, MD, Henry W. Lim, MD ⁎ 
Photomedicine and Photobiology Unit, Department of Dermatology, Henry Ford Health System, Detroit, Michigan
∗Correspondence to: Henry W. Lim, MD, Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Blvd, Ste 800, Detroit, MI 48202Department of DermatologyHenry Ford Medical Center3031 West Grand BlvdSte 800DetroitMI48202
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflict of interest: Dr Lyons is a subinvestigator for Incyte, Beiersdorf, Unigen Inc, General Electric, Lenicura, Estée Lauder, Miragen, Biofrontera, Pfizer, and L’Oréal. Dr Hamzavi is an investigator for the Patient-Centered Outcomes Research Institute, Incyte Corporation, Beiersdorf, Estée Lauder, Unigen Inc, Ferndale Healthcare Inc, Pfizer, Allergan, and Johnson & Johnson. Dr Lim is an investigator for Incyte, L’Oréal, Pfizer, and the Patient-Centered Outcomes Research Institute; has served as consultant for Pierre Fabre, ISDIN, Ferndale, and Galderma; and has participated as a speaker in general educational sessions for Johnson & Johnson and Ra Medical Systems. Dr Torres has no conflicts of interest to declare. |
|
| IRB approval status: Exempt. |
|
| Reprints not available from the authors. |
© 2020
Publié par Elsevier Masson SAS.
Vol 84 - N° 2
P. e95-e96 - février 2021 Retour au numéro
Article précédent
- Commentary on “Role of phototherapy in the era of biologics”
- Aysenur Botsali
- Volunteer and work experiences among dermatology residency applicants
- Swetha Atluri, Justine R. Seivright, Vivian Y. Shi, Jennifer L. Hsiao
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?